Fny Investment Advisers, LLC Tyme Technologies, Inc. Transaction History

Fny Investment Advisers, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Jan 22, 2019	SELL	$2.01 - $4.21 $15,074 - $31,575	-7,500 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$2.18 - $3.44 $16,350 - $25,800	7,500 New	7,500 $20,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.